Medications Updated During September 2009, From Newest to Oldest, Page 5

Page 5 of 17 « First Page « … 3 4 5 6 7 … 10 15 … » Last Page »

PROCHLORPERAZINE (PROCHLORPERAZINE MALEATE)

INDICATIONS AND USAGE For control of severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. However, prochlorperazine is not the first drug to…

STAT RX USA LLC24 September 2009

Kit For the Preparation of Technetium Tc 99m Medronate For Injection (Medronic Acid)

Technetium Tc 99m Medronate Injection may be used as a bone imaging agent to delineate areas of altered osteogenesis. CONTRAINDICATIONS: None known. WARNINGS: This class of compounds is known to complex cations such as calcium. Particular caution…

Pharmalucence, Inc.24 September 2009

Westcort (Hydrocortisone Valerate)

Westcort Ointment is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. CONTRAINDICATIONS: Westcort Ointment is contraindicated in those…

Ranbaxy Laboratories Inc.23 September 2009

Linezolid

Linezolid formulations are indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms (see PRECAUTIONS. Pediatric and DOSAGE AND ADMINISTRATION.). Linezolid is not indicated for the…

Glenmark Generics Inc., USA22 September 2009

FLUOROURACIL

Fluorouracil Cream is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with…

Physicians Total Care, Inc.22 September 2009

Page 5 of 17 « First Page « … 3 4 5 6 7 … 10 15 … » Last Page »

FDA Medwatch

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Sun, 20 Sep 2020. Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product…
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Wed, 16 Sep 2020. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.